title: In vitro methods for the assessment of primary local effects of topically applied preparations.
abstract: Three 'alternative' methods for the screening of the primary irritation potentials of topically applied preparations and raw materials are presented as a test battery and their in vitro endpoints are compared with in vivo data. The first method is the intermediate test on the chorioallantoic membrane of hens' fertilized eggs, which is generally proposed for the prediction of the irritation potential of chemicals. Relevant test parameters, such as the time-dependent appearance of hemorrhages, vascular lysis and coagulation, are used to classify the test substances. Secondly, cytotoxicity tests with Balb/c 3T3 fibroblasts are used to characterize the influence of test materials on cellular homeostasis and viability, which is quantified by the dose-dependent uptake of Neutral red. As a second parameter changes in the cellular protein level can be easily measured by subsequent staining with Kenacid blue. Finally, the third approach to in vitro evaluation is presented in the form of the red blood cell assay, a rapid photometric assay which permits distinguishing basically between damage to the membrane and to proteins as endpoints which correlate with lesions observed on the conjunctiva, iris and cornea in the eye and the acute inflammatory responses evoked during epicutaneous irritancy testing. Changes in the optical behavior of oxyhemoglobin are used as the inherent indicator for monitoring both endpoints and their interrelations. These methods are proposed and can be used advantageously for testing newly developed topical preparations and their ingredients in view of their local irritation potential without further use of animal testing. Moreover, they can also be used for screening chemicals.
authors.affiliation: Paul Gerson Unna-Skin Research Center, Beiersdorf (BDF) AG, Hamburg, FRG.
authors.forename: W J
authors.initials: WJ
authors.lastname: Pape
authors.forename: U
authors.initials: U
authors.lastname: Hoppe
mesh_terms: D000287:Administration, Topical; D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D002417:Cattle; D002470:Cell Survival / Q000187:drug effects; D002642:Chick Embryo; D002823:Chorion / Q000187:drug effects; D004912:Erythrocytes / Q000187:drug effects; D005347:Fibroblasts / Q000187:drug effects; D006461:Hemolysis / Q000187:drug effects; D006470:Hemorrhage / Q000139:chemically induced; D007509:Irritants / Q000008:administration & dosage / Q000633:toxicity*; D051379:Mice; D008807:Mice, Inbred BALB C; D010108:Oxyhemoglobins / Q000378:metabolism; D011485:Protein Binding; D011489:Protein Denaturation; D012710:Serum Albumin, Bovine / Q000276:immunology; D012867:Skin / Q000187:drug effects*; D013501:Surface-Active Agents / Q000633:toxicity; D013552:Swine
chemical_list: D001798:Blood Proteins; D007509:Irritants; D010108:Oxyhemoglobins; D013501:Surface-Active Agents; D012710:Serum Albumin, Bovine